09 January 2002
Detecting the replication of the hepatitis B virus using the ImmunoMax technique following treatment with interferon-alpha in children with chronic hepatitis.
Jacek Wysocki, Aldona Kasprzak, Maciej Zabel, Joanna Surdyk-ZasadaMed Sci Monit 2002; 8(1): PR1-7 :: ID: 420958
Abstract
BACKGROUND: Children with HBV in Poland are treated with preparations ofinterferon-alpha (IFN-alpha). The continuing lack of complete response to this type of anti-viral therapyremains to be explained. The application of cell biology techniques to identify the viral componentsin situ makes it possible to clarify the association between the distribution of the virus and morphologicalinjury to the liver, the immune response of the host, and clinical symptoms in the natural course ofinfection. Our study was intended to evaluate HBV expression in liver biopsies taken an average of twoyears after completion of IFN-a therapy in 10 children with serological markers of persistent HBV infection.MATERIAL/METHODS: For the immunocytochemical detection of HBcAg and for the hybridocytochemical detectionof HBV-DNA, the avidin-biotin-peroxidase (ABC) technique was employed, as well as classical in situ hybridization,both additionally amplified using the ImmunoMax technique. HBcAg and HBV-DNA levels were estimated usinga semiquantitative technique. RESULTS: Our study demonstrated persistent active replication of HBV inthe liver in all examined children. A mixed pattern of HBcAg localization prevailed (noted in cell nuclei,cytoplasm and cell membranes) with a somewhat lower proportion of involved cells and a more evident membranelocalization of HBcAg, as compared to results obtained before treatment. HBV-DNA was observed in thecytoplasm of a fraction of hepatocytes similar to that noted before therapy. CONCLUSIONS: The ImmunoMaxtechnique was found to be highly suitable for in situ monitoring of HBV replication after terminationof IFN-a treatment. Children with focal distribution of HBcAg and HBV-DNA have the potential for earliereradication of the virus from their livers.
Keywords: Adolescent, Avidin, Biotin, Child, Cytological Techniques, Follow-Up Studies, Hepatitis B Core Antigens, Hepatitis B virus, Hepatitis, Chronic, In Situ Hybridization, Interferon-alpha, Liver, Peroxidase, Time Factors
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952